Skip to main content
Equibles

Romy

Analyst

Kempen

Equibles does not estimate personal net worth.

About Romy

Romy is recorded as Analyst at Kempen. Romy has spoken on 3 earnings calls across 3 companies, most recently for Gubra A/S on August 20, 2026. Those appearances were for Gubra A/S, VALNEVA and Valneva SE (VALN). The companies whose calls Romy spoke on are classified in the Healthcare sector.

Romy on recent calls

“Just another follow-up on UCN2, so you highlight several potential indication expansion opportunities beyond obesity, so we're just wondering what specifically from the study next year will determine prioritizations next, and how soon can we expect this?”
Analyst — Kempen, Gubra Q2 2026 ·
“So I was wondering if the decline we saw for Q1 of this year was solely driven by phasing with the USDOD, or was there also contributions from the private travel markets.”
Analyst — Kempen, Q1 2026 Financial Results ·
“So I was wondering if the decline we saw for Q1 of this year was solely driven by phasing with the USDOD, or was there also contributions from the private travel markets.”
Analyst — Kempen, Earnings conference call (announced in 6-K) ·

Affiliation history

  • Kempen

    Analyst

    Transcript header (unverified)

    Current

Company network

Gubra A/S

Biotechnology · Healthcare

1 appearance Latest appearance 2026-08-20

VALNEVA

Biotechnology · Healthcare

1 appearance Latest appearance 2026-05-13

Recent activity